市场调查报告书
商品编码
1567812
到 2030 年北美分子光谱市场预测 - 区域分析 - 按产品、技术和应用North America Molecular Spectroscopy Market Forecast to 2030 - Regional Analysis - by Product, Technology, and Application |
2022年北美分子光谱市值为15.6861亿美元,预计2030年将达到23.3287亿美元;预计2022年至2030年复合年增长率为5.1%。
分子光谱的日益普及和使用推动了北美分子光谱市场
分子光谱用于药品和其他生物技术产品的研发 (R&D)。近红外线(NIR)光谱是分子光谱类型之一,由于其相对于其他分析技术的巨大优势,近年来在製药行业获得广泛认可;它有助于轻鬆进行样品製备,并具有从单一光谱中获取化学和物理样品参数的能力。拉曼光谱也是药物发现和药物开发中应用的强大分析技术之一。它用于研究结构活性关係并改善反应条件和其他参数,例如多晶型物和製剂筛选,从而达到将药物化合物从发现到开发所需的规模。此外,核磁共振(NMR)波谱被认为是一种强大的工具,并且越来越多地使用该技术来开发新型疗法。 2021 年 3 月,布鲁克公司宣布推出永磁傅立叶 80 系统,这是一种下一代 80 MHz 高性能傅立叶变换 NMR 桌上型光谱仪,用于具有行业标准自动化选项的多核梯度光谱。
北美分子光谱市场概况
北美分子光谱市场分为美国、加拿大和墨西哥。该地区的市场成长是由生物技术和生物製药公司推出的产品数量不断增加以及主要市场参与者的存在所推动的。此外,各种製药和生物技术公司以及学术和研究机构的广泛研发预计将刺激北美分子光谱市场的成长。美国是北美分子光谱市场的最大贡献者。
北美分子光谱市场收入及 2030 年预测(百万美元)
北美分子光谱市场细分
北美分子光谱市场分为产品、技术、应用和国家。
根据产品,北美分子光谱市场分为仪器和配件。 2022年,仪器仪表领域将占据更大的市场份额。
从技术角度来看,北美分子光谱市场分为紫外-可见光光谱、红外光谱、核磁共振光谱、拉曼光谱、近红外光谱等。紫外-可见光光谱领域在 2022 年占据最大的市场。
依应用划分,北美分子光谱市场分为学术与研究应用、生物技术应用、製药应用等。 2022 年,学术和研究应用领域占据最大的市场份额。
根据国家/地区,北美分子光谱市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美分子光谱市场。
Horiba Ltd、Thermo Fisher Scientific Inc、Merck KGaA、Revvity Inc、Ostec Instruments、JEOL Ltd、Shimadzu Corp、JASCO Corp、Bruker Corp、Agilent Technologies, Inc.、Oxfords Instruments plc 和 Teledyne Princeton Instruments 是一些领先的营运公司北美分子光谱市场。
The North America molecular spectroscopy market was valued at US$ 1,568.61 million in 2022 and is expected to reach US$ 2,332.87 million by 2030; it is estimated to register a CAGR of 5.1% from 2022 to 2030.
Growing Adoption and Use of Molecular Spectroscopy Fuels North America Molecular Spectroscopy Market
Molecular spectroscopy is used in the research and development (R&D) of pharmaceuticals and other biotechnological products. Near-infrared (NIR) spectroscopy is one of the types of molecular spectroscopy that has gained wide recognition in the pharmaceutical industry in recent years due to its huge advantages over other analysis techniques; it helps in effortless sample preparation and exhibits the ability to obtain chemical and physical sample parameters from a single spectrum. Raman spectroscopy is also one of the powerful analytical techniques implemented in drug discovery and pharmaceutical development. It is used to study structural activity relationships and improve reaction conditions and other parameters, such as polymorph and formulation screening, that lead to the scale required to move drug compounds from discovery to development. Further, nuclear magnetic resonance (NMR) spectroscopy is considered a robust tool, and the use of this technique for developing novel therapeutics has increased. In March 2021, Bruker Corp. announced the launch of a permanent magnet Fourier 80 system, a next-generation, 80 MHz high-performance Fourier transform NMR benchtop spectrometer used for multinuclear gradient spectroscopy with industry-standard automation options.
North America Molecular Spectroscopy Market Overview
The North America molecular spectroscopy market is segmented into the US, Canada, and Mexico. The market growth in this region is driven by the increasing number of product launches by biotechnology and biopharmaceutical companies and the presence of key market players. In addition, extensive R&D by various pharmaceutical and biotechnology companies and academic & research institutes is expected to stimulate the molecular spectroscopy market growth in North America. The US is the largest contributor to the molecular spectroscopy market in North America.
North America Molecular Spectroscopy Market Revenue and Forecast to 2030 (US$ Million)
North America Molecular Spectroscopy Market Segmentation
The North America molecular spectroscopy market is segmented into product, technology, application, and country.
Based on product, the North America molecular spectroscopy market is bifurcated into instrument and accessories. The instrument segment held a larger market share in 2022.
In terms of technology, the North America molecular spectroscopy market is categorized into UV-Visible spectroscopy, infrared spectroscopy, nuclear magnetic resonance spectroscopy, Raman spectroscopy, Near-infrared spectroscopy, and others. The UV-Visible spectroscopy segment held the largest market share in 2022.
By application, the North America molecular spectroscopy market is segmented into academic and research applications, biotechnology applications, pharmaceutical applications, and others. The academic and research applications segment held the largest market share in 2022.
Based on country, the North America molecular spectroscopy market is segmented into the US, Canada, and Mexico. The US dominated the North America molecular spectroscopy market share in 2022.
Horiba Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Revvity Inc, Ostec Instruments, JEOL Ltd, Shimadzu Corp, JASCO Corp, Bruker Corp, Agilent Technologies, Inc., Oxfords Instruments plc, and Teledyne Princeton Instruments are some of the leading companies operating in the North America molecular spectroscopy market.